Current implantable biomaterials often rely on synthetic or animal-derived polymers, which can be costly, poorly biocompatible, or environmentally unsustainable. There is growing interest in finding plant-based or fungal alternatives that meet the demanding requirements of medical-grade applications. Chinova Bioworks, a Canadian biotechnology company, specializes in producing chitosan from mushrooms for use in preservative applications. The […]
Read More